In addition, we store sensitive data, including proprietary business information, intellectual property and confidential employee or other personal data, on our servers and databases. We also tested management’s controls to validate that the data used in the accrual estimate was complete and accurate. Representing over 25 major suppliers, we offer our customers a broad product portfolio, just-in-time delivery from multiple stocking locations and local technical support.

GLOBAL REGULATORY COMPLIANCE Our regional tech centers around the world offer regulatory support and product stewardship expertise to help you qualify your products BIO-COMPATIBILITY APPLICATIONS Bio-compatible additives and colorants, tested under USP Class VI and ISO 10993, allow your materials to achieve required functional performance while meeting brand and color standards STERILIZATION REQUIREMENTS A standard color range and deliberate formulations provide stability under harsh sterilization methods AUTHENTICATION TECHNOLOGY Protect your brands with our Percept™ anti-counterfeit, security and tracking taggant technologies, or utilize radiopacifiers for placement protection LASER MARKING SOLUTIONS Optimized for color and contrast without diminishing physical property characteristics for branding, inventory management, data coding, or universal device identification PRODUCT & PROCESS OPTIMIZATION Maximize production throughput or eliminate waste with solutions including dimensional stabilization, cycle time reducers, chemical foaming agents, nucleation or hybrid technology ONCOLOR™ HC Colorants designed to be healthcare-friendly. Enhance your product performance and processing efficiencies, and have our technical support and services at your fingertips.

CESA™ Block Additives Antiblocking PRODUCT SELECTION GUIDE Unmodified film and sheet can adhere, causing problems of separation. CESA™ Block additives modify the surface characteristics and improve the coefficient of the friction of the sheet or film, preventing self-adhesion.

The amounts and values for the facility(ies) identified below are accurate, based on reasonable estimates using available data.  The data for the facility(ies) that I represent are hereby submitted to the programs identified below using the Single Window Reporting Application. I also acknowledge that the data will be made public.

Seller warrants good and clear title in goods subject to the sale (“Product”) and that the Product conforms at the time of shipment to a Certificate of Analysis, a Certificate of Compliance, or a Product Specification Sheet, if any such document exists, and other specifications signed by Seller (“Specifications”). Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice. Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

Seller warrants good and clear title in goods subject to the sale (“Product”) and that the Product conforms at the time of shipment to a Certificate of Analysis, a Certificate of Compliance, or a Product Specification Sheet, if any such document exists, and other specifications signed by Seller (“Specifications”). Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice. Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

Seller warrants good and clear title in goods subject to the sale (“Product”) and that the Product conforms at the time of shipment to a Certificate of Analysis, a Certificate of Compliance, or a Product Specification Sheet, if any such document exists, and other specifications signed by Seller (“Specifications”). Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice. Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

Despite using an acrylic sheet with built-in light diffusion technology, the light source was plagued by visual “hot spots.” Also, the acrylic sheets required an additional process to cut them to size before thermoforming, which led to excessive waste and disposal costs. Instead of purchasing pre-fabricated acrylic sheet that contained a costly diffusion additive, the Smartbatch solution enabled the customer to reduce its material costs by 50%.

Indien u zich in de EU of het VK bevindt, geldt de overeenkomst voor internationale gegevensoverdracht binnen de bedrijvengroep (Intra Group International Data Transfer Agreement) die Avient is aangegaan.

S&P 500 PolyOne Corporation Page 9 2006 Q1 2015 2015 Target “Where we were” “Where we are” (Est. in 2012) 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 16.2% 12 – 16% Global Specialty Engineered Materials 1.1% 16.3% 12 – 16% Designed Structures & Solutions 1.4% (2012) 2.7% 8 – 10% Performance Products & Solutions 5.5% 6.5% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 69% 65 – 75% 3) ROIC 5.0% 11.4% 15% 4) Adjusted EPS Growth N/A 5% Double Digit Expansion Proof of Performance & 2015 Goals PolyOne Corporation Page 10 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 11 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) $800 $450 $450 $1,700 PolyOne Corporation Page 13 60% 98% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q1 2015 Pension Funding** As of March 31, 2015 Debt Maturities & Pension Funding – 3/31/15 Net Debt / EBITDA* = 2.1x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2015 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2015 PolyOne Corporation Page 14 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased over 500k shares in Q1 2015  Repurchased 11.8 million shares since early 2013  8.2 million shares are available for repurchase under the current authorization PolyOne Corporation Page 15 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Net debt to adjusted EBITDA is calculated as follows: Three Months Twelve Months Three Months Trailing Twelve Months (TTM) (In millions) March 31, 2014 December 31, 2014 March 31, 2015 March 31, 2015 Short-term portion and current portion of long-term debt $ 12.8 $ 61.8 $ 61.9 Long-term debt 968.1 962.0 1,049.2 Less: Cash and cash equivalents (238.3) (238.6) (226.4) Net Debt $ 742.6 785.2 884.7 Income before income taxes $ 39.9 $ 88.4 $ 53.3 $ 101.8 Interest expense, net 15.5 62.2 16.1 62.8 Depreciation and amortization 32.8 123.9 25.1 116.2 Special items, impact on operating income 22.9 164.9 9.3 151.3 Accelerated depreciation included in special items (6.8) (23.1) (0.1) (16.4) Adjusted EBITDA $ 104.3 $ 416.3 $ 103.7 $ 415.7 Net Debt/TTM Adjusted EBITDA 2.1 POL IR Presentation - Updated for 2015 - 5-5-15 WF ��PolyOne Investor Presentation�Wells Fargo Industrial & Construction Conference�May 2015�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results Proof of Performance & 2015 Goals Innovation Drives Earnings Growth Megatrends Aligned with Key End Markets A Rich Pipeline of Opportunity Debt Maturities & Pension Funding – 3/31/15 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return PolyOne Core Values Why Invest In PolyOne?